Extensively drug-resistant (XDR-TB ... statement in 2008 for the use of molecular line-probe assays for the rapid screening of patients at risk of MDR-TB. This was extended to 27 countries ...
The U.S. Food and Drug Administration on Thursday announced it has authorized the use of the Healgen Rapid Check COVID-19/Flu ...
NEW YORK - Intelligent Bio Solutions Inc. (NASDAQ:INBS), a medical technology company with a market capitalization of $6.93 million, announced Monday that it will upgrade its Intelligent ...
According to Grand View Research, the European and Middle Eastern drug screening markets are projected to grow significantly by 2030, with Europe expected to reach $3.6 billion and the Middle East and ...
The global drug screening market is set to experience remarkable growth, expanding from USD 7.3 billion in 2023 to a ...
However, one additional interest that is perhaps less well-known is the company’s significant investments in the world of biology and drug discovery ... challenges. The rapid growth of ...
Quantum Traffic Management transitions from saliva and urine testing to non-invasive, in-house fingerprint sweat-based drug screening Most recent client added to INBS’s portfolio of more than 400 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback